[Chronic toxicity of bufexamac in the rat and monkey].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J Roba.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
We compared the binding properties of [3H]nitrendipine in heart membranes from 9- and 24-week-old spontaneously hypertensive rats (SHR) and their normotensive controls (WKY). In native membranes of 9-week-old SHR and WKY and of 24-week-old WKY, [3H]nitrendipine binds to a single class of binding sites with high affinity (Kd, approximately equal to 0.20 nM) and high capacity (Bmax, approximately equal to 96 fmol X mg protein-1). By contrast, in membranes of 24-week-old, SHR, Kd and Bmax increased significantly to 0.30 nM and 137 fmol X mg protein-1, respectively. Addition of 1 mM Ca2+ had no effect on [3H]nitrendipine binding in WKY but decreased the Kd value to 0.18 nM in 24-week-old SHR. Bmax remained 40% above the value in WKY. Inhibition and activation of specific binding by nifedipine and dilitiazem are identical in both strains. We conclude that the differences in [3H]nitrendipine binding in hearts of aged SHR are due to a decreased Ca2+ content and might reflect a functional adaptation.
Explore the source record for details and available documents.
Explore the source record for details and available documents.